Company Overview and News

 
Pub sector kicks off with sale of Montague for $3.3 million

2018-02-20 smh.com.au
A South Melbourne pub has kicked off the new year in Melbourne’s hospitality sector, transacting for around $3.3 million, as a fresh crop of hotels comes on the market.

 
ALH hotels in Melbourne hit market as pub sector heats up

2017-10-06 theage.com.au
The Royal Hotel in Melbourne's Sunbury, leased to Woolworths-backed operator ALH Group, is to be offloaded by a private NSW investor, hot on the heels of another ALH-operated pub, the Berwick Inn, hitting the market.

 
ALH hotels in Melbourne hit market as pub sector heats up

2017-10-06 smh.com.au
The Royal Hotel in Melbourne's Sunbury, leased to Woolworths-backed operator ALH Group, is to be offloaded by a private NSW investor, hot on the heels of another ALH-operated pub, the Berwick Inn, hitting the market.

 
Brookfield Prime Property and ALE Property take out BDO AREIT honours

2016-12-13 theage.com.au
Office towers, pubs, agriculture and healthcare investments took out line honours in the 22nd BDO Australian real estate investment trust survey.

 
Brookfield Prime Property and ALE Property take out BDO AREIT honours

2016-12-13 smh.com.au
Office towers, pubs, agriculture and healthcare investments took out line honours in the 22nd BDO Australian real estate investment trust survey.

 
Pubs under the spotlight

2016-08-07 theage.com.au
Listed pub landlord ALE Property is to work with its tenant, the Woolworths-associate ALH, to develop underused parts of around 970,000 square metres of land to enhance returns.

 
Pubs under the spotlight

2016-08-07 smh.com.au
Listed pub landlord ALE Property is to work with its tenant, the Woolworths-associate ALH, to develop underused parts of around 970,000 square metres of land to enhance returns.

 
Intelligent Investor: what to do when sharemarket yield becomes expensive

2016-06-07 smh.com.au
For 20 years now, Japanese interest rates haven't risen above 1 per cent. The demand for safes over that period barely budged. Japanese savers weren't getting much in the way of returns but at least they got something.

 
 
 
Appendix 4D - 31 December 2015

2016-02-16 asx.com.au

 
Change in substantial holding

2016-02-11 asx.com.au

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...